PacBio signs $100M at-the-market stock sales agreement with Allen & Company

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Sales Agreement dated Nov 10, 2026 lets PacBio sell up to $100,000,000 of common stock (PACB) from time to time through an at-the-market program.
Allen & Company LLC acts as sales agent and is paid up to 3.0% of aggregate gross proceeds from shares it sells.
Either party may terminate on 10 days' notice; Allen may terminate immediately on certain events, including a material adverse change.
Shares are issued under the automatic shelf Form S-3ASR (File No. 333-293751) filed Feb 25, 2026; prospectus supplement filed Nov 10, 2026.
PacBio has no obligation to sell and controls share count, timing, daily limits and minimum price; it may suspend offers at any time.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.